FDA Approves First Medication for Obstructive Sleep Apnea
Today, the U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity, to be used in...
FDA approves weight loss drug Zepbound for sleep apnea - NBC News
Dec 20, 2024 · Zepbound, Eli Lilly’s weight loss drug, can now be used to treat obstructive sleep apnea in adults with obesity, the FDA said. It's the first medication for the disorder, which …
Zepbound Approved to Treat Obstructive Sleep Apnea
Jan 3, 2025 · Zepbound is the first medication for obstructive sleep apnea to receive FDA approval . This breakthrough for sleep apnea treatment received FDA approval in December …
Tirzepatide reduced sleep apnea severity by up to nearly two …
INDIANAPOLIS, April 17, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive topline results of the SURMOUNT-OSA phase 3 clinical trials that showed …
FDA approves Zepbound® (tirzepatide) as the first and only …
Dec 20, 2024 · This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about Zepbound (tirzepatide) as a …
FDA Approves Zepbound for Obstructive Sleep Apnea - WebMD
Dec. 23, 2024 -- The FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity.
FDA approves weight-loss drug Zepbound for obstructive sleep apnea
Dec 20, 2024 · The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound. The medicine, part of …
FDA approves weight loss drug Zepbound to treat sleep apnea : …
Dec 21, 2024 · The Food and Drug Administration has authorized the use of Zepbound for adults with obesity and moderate to severe obstructive sleep apnea.
Tirzepatide for the Treatment of Obstructive Sleep Apnea and …
Jun 21, 2024 · Positive airway pressure (PAP) therapy improves the apnea–hypopnea index (AHI, the number of apneas and hypopneas during an hour of sleep) and reduces symptoms related …
First Sleep Apnea Drug, Zepbound (Tirzepatide), Gets FDA Okay
Dec 27, 2024 · Malhotra A et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. The New England Journal of Medicine. June 21, 2024. Zepbound Approval for Sleep …
- Some results have been removed